Breaking News

Novartis AG (0QLR)

Symbol	Exchange	Currency
NOVN	Switzerland	CHF	Delayed
NOVNz	BATS Europe	CHF	Delayed
NVS	NYSE	USD	Real-time
NVSEF	OTC Markets	USD	Delayed
0QLR	London	CHF	Real-time
NVSN	Mexico	MXN	Delayed
NOVZn	Frankfurt	EUR	Delayed
NVS-RMDR	Moscow	RUB	Real-time

Add to/Remove from a Portfolio Add to Watchlist

86.76 -1.30 -1.48%

27/05 - Closed. Currency in CHF ( Disclaimer )

Volume: 2,388,599
Bid/Ask: 0.00 / 0.00
Day's Range: 86.76 - 86.76

Type: Equity

Market: United Kingdom

ISIN: CH0012005267

SEDOL: B10S3M3

Novartis AG Company Profile

Read the Novartis company profile to learn more about the business and the management team. View employee data, company address and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

110000

Equity Type

ORD

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Contact Information

Address Lichtstrasse 35
Basel, 4056
Switzerland

Phone 41 61 324 1111

Fax 41 61 324 8001

Web www.novartis.com

Top Executives

Name	Age	Since	Title
Joerg Reinhardt	66	1999	Independent Non-Executive Chairman
Daniel L. Vasella	69	1996	Honorary Chairman
William Thomas Winters	61	2013	Independent Non-Executive Director
Charles L. Sawyers	63	2013	Independent Non-Executive Director
Nancy C. Andrews	64	2015	Independent Non-Executive Director
Bridgette P. Heller	61	2020	Independent Non-Executive Director
François Adrianus van Houten	62	2017	Independent Non-Executive Director
Simon E. Moroney	63	2020	Independent Vice Chairman of the Board
Ana de Pro Gonzalo	-	2022	Director
Daniel Hochstrasser	-	2022	Independent Director
Andreas von Planta	67	2006	Independent Non-Executive Director
Ton Buechner	57	2016	Independent Non-Executive Director
Elizabeth Doherty	65	2016	Independent Non-Executive Director
Patrice Bula	66	2019	Lead Independent Director
Sidonie Golombowski-Daffner	-	-	Chairperson & President of Advanced Accelerator Applications

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

NOVN Comments

Write your thoughts about Novartis AG

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Lee Taylor Dec 01, 2021 10:39

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Novartis is trading at a value last seen in 2018; the funds released from a Sandoz divestment need to be directed towards further patient innovation from this Swiss Pharma major …

0 0

Report

Lukas Bednall Sep 28, 2021 15:36

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Hi Guys, I have been invested in Novartis for 5 years and have closely followed the pharmaceutical industry for years. I have been very disappointed with the returns and am looking to transfer my portfolio into riskier assets. Upon research, I think I may have found an even better pharmaceutical company going by the name of SpectrumX. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trials for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.

1 1

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="230909495">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="230909495" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="230909495">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="230909495">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	7,585.46	+20.54	+0.27%
DAX	14,462.19	+230.90	+1.62%
Euro Stoxx 50	3,808.86	+68.55	+1.83%
US 30	33,278.1	+640.9	+1.96%
US 500	4,169.4	+111.6	+2.75%
Nikkei 225	26,781.68	+176.84	+0.66%
GBP Index	74.31	+0.24	+0.32%

Brent Oil	115.32	+1.15	+1.01%
Crude Oil WTI	115.07	+0.98	+0.86%
Gold	1,851.64	+4.04	+0.22%
Silver	22.130	+0.165	+0.75%
Copper	4.3225	+0.0635	+1.49%
London Cocoa	1,716.00	-3.00	-0.17%
London Wheat	314.75	-5.25	-1.64%

GBP/USD	1.2629	+0.0035	+0.28%
EUR/USD	1.0735	+0.0011	+0.10%
USD/JPY	127.13	-0.01	-0.01%
EUR/GBP	0.8505	-0.0007	-0.08%
USD/CAD	1.2723	-0.0049	-0.38%
GBP/JPY	160.57	+0.46	+0.28%
AUD/USD	0.7161	+0.0063	+0.89%

Lloyds Banking	45.23	-0.10	-0.22%
Vodafone Group PLC	130.14	-1.28	-0.97%
Barclays	170.38	+2.70	+1.61%
BT Group	184.25	-1.30	-0.70%
HSBC	532.40	+7.10	+1.35%
BHP Billiton Ltd	2,506.50	+85.50	+3.53%
Exxon Mobil	97.59	+0.95	+0.98%

Recent Quotes

	Name	Price	Chg.	Chg. %
	0QLR	86.76	-1.30	-1.48%

Market Movers

Name	Last	Chg. %	Vol.
Vodafone Group PLC	130.14	-0.97%	115.13M
BP	430.65	-1.06%	32.50M
Glencore	526.20	+1.35%	24.12M
Shell	2,380.0	-1.00%	12.89M
Anglo American	3,803.0	+1.22%	2.90M
Rio Tinto PLC	5,702.0	+1.26%	1.97M
AstraZeneca	10,580.0	+0.32%	1.13M

Name	Last	Chg. %	Vol.
Octopus Renewables	11,080.00	+1000.00%	266.20K
Saipem	5.58	+414.46%	793.16K
Tiger	0.35	+100.00%	4.76M
OPAP SA	13.50	+26.76%	84.82K
Funding Circle	71.10	+22.59%	469.56K
Brandshield Systems	9.65	+16.97%	2.12M
Rurelec	0.5800	+16.00%	3.02M

Name	Last	Chg. %	Vol.
Dassault Aviation	157.80	-82.91%	3.01K
Dassault Systemes	39.47	-81.15%	338.44K
Tilray	4.42	-75.59%	0
Atlas Copco B	93.07	-75.37%	52.65K
Tomra Systems	184.06	-47.07%	6.71K
British Honey	35.50	-29.70%	0
Fuchs Petrolub AG	24.30	-28.53%	2.15K